Pharma Giants Pay Up as Oregon Nets $10 Million in Opioid Accountability Deal

Oregon will receive $10.1 million as part of a $720 million settlement reached by Attorneys General from nine states with eight pharmaceutical companies accused of fueling the opioid crisis.

The settlement, announced by Oregon Attorney General Dan Rayfield, is part of ongoing national efforts to hold opioid manufacturers accountable for the devastation caused by prescription painkillers.

Distribution of Oregon’s Settlement Funds

Of Oregon’s share, 55% will be distributed to counties and cities to support local prevention, treatment, and recovery initiatives.

The remaining 45% will go to the state’s Opioid Settlement Prevention, Treatment, and Recovery Fund, established in 2022.

Companies Involved and Payment Details

The eight companies participating in the settlement are:

• Mylan (now part of Viatris): $284.4 million paid over nine years
• Hikma: $95.8 million paid over one to four years
• Amneal: $71.8 million paid over ten years
• Apotex: $63.7 million paid in a single year
• Indivior: $38 million paid over four years
• Sun: $31 million paid over one to four years
• Alvogen: $18.7 million paid in a single year
• Zydus: $14.9 million paid in a single year

Oregon Chooses Additional Funds and New Restrictions

In addition to financial payments, Oregon has opted to receive extra funding (rather than harm reduction medications) offered as part of the agreements.

Seven of the companies—excluding Indivior—are now barred from advertising or promoting opioids, prohibited from manufacturing or distributing pills containing more than 40 milligrams of oxycodone, and required to implement systems for monitoring and reporting suspicious orders.

Indivior has agreed to stop producing and selling opioid medications for the next ten years, though it will continue to market treatments for opioid use disorder.

Broader Context and Previous Settlements

The multistate negotiations were led by Attorneys General from Oregon, California, Colorado, Illinois, New York, North Carolina, Tennessee, Utah, and Virginia.

Oregon’s new $10.1 million share adds to the $700 million the state has secured since July 2021 from national opioid-related settlements, including a $66 million agreement announced in June with the Sackler family and Purdue Pharma.

Attorney General Rayfield emphasized the ongoing commitment to seek justice and hold pharmaceutical companies accountable for the harm inflicted on Oregon families and communities.